A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
Recruiting · NCT06249867 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 2 | 2026-10-09 | NCT06249867 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Oliver Blanchard | 1 |
| Université de Montréal | 43 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Montreal Neurological Institute | Montreal | Canada | 5 |
| Ottawa Hospital Research Institute | Ottawa | Canada | 11 |